While all patients are treated for obstructive jaundice in resectable pancreatic cancer before surgical resection, data over the past decade indicate that systematic PBD is linked with increased perioperative complications and morbidity when compared with undertaking direct surgery. With new evidence of potential adverse events, reassessment of the role of routine PBD is required. Read more . . .
Currently, pancreatic adenocarcinoma is identified as one of the main causes of cancer-related morbidity and mortality with dismal long term survival after diagnosis. At presentation, advanced disease is identified in nearly 85% of pancreatic cancer patients, precluding curative surgical resection. In candidates for surgery, preoperative biliary drainage (PBD) has been carried out since the 1960s for improving surgical outcomes.